Methotrexate Neurological Toxicities: Current State-of-the-Art
British Journal of Hospital Medicine · 22.06.2026 · 87 (6)
DOI: 10.31083/bjhm55135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 22.06.2026. Verfasst von Abbie Wilson und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, G61 1QH Glasgow, UK. Hauptthemen laut MEDLINE: Methotrexate, Neurotoxicity Syndromes, Antimetabolites, Antineoplastic. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK (CRUK) Programme Foundation Award, Children with Cancer UK.
Abstract (Originalsprache)
Methotrexate is a highly effective anti-folate drug, used for a range of oncological and inflammatory conditions. Toxic effects of methotrexate on the bone marrow, mucosa, liver and kidneys are widely appreciated; however, clinicians may be less familiar with neurotoxic side-effects. Neurotoxicity is primarily reported in those receiving high-dose or intrathecal methotrexate; however, it may occur in patients receiving low-dose treatment. Symptoms range from acute headache/somnolence, sub-acute onset of seizures/stroke-like symptoms, to long-term cognitive and behavioural difficulties. Stroke-like symptoms occur several days after administration when the patient may be out of the hospital, meaning that acute care providers must be able to recognise and appropriately manage these conditions. The mechanism by which methotrexate causes neurotoxicity remains poorly understood, and although some treatments and preventative agents have been identified, they lack robust evidence at present, representing a key area for future research. This article aims to provide a state-of-the-art review of methotrexate neurotoxicity, which will increase physician awareness of this condition, its presentation, and to highlight evidence and research gaps relating to treatment and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, G61 1QH Glasgow, UK.
Förderung
- Cancer Research UK (CRUK) Programme Foundation Award
- Children with Cancer UK
Zitieren
APA
Wilson, A., & Halsey, C. (2026). Methotrexate Neurological Toxicities: Current State-of-the-Art. British Journal of Hospital Medicine, 87(6). https://doi.org/10.31083/bjhm55135
Vancouver
Wilson A, Halsey C. Methotrexate Neurological Toxicities: Current State-of-the-Art. British Journal of Hospital Medicine. 2026;87(6). doi:10.31083/bjhm55135
BibTeX
@article{Wilson2026,
author = {Wilson, Abbie and Halsey, Christina},
title = {Methotrexate Neurological Toxicities: Current State-of-the-Art},
journal = {British Journal of Hospital Medicine},
year = {2026},
volume = {87},
number = {6},
doi = {10.31083/bjhm55135}
}
EUVIMED